DHB Dhb Industries, Inc.

WASHINGTON, Sept. 30 /PRNewswire/ -- Klafter & Olsen LLP has been retained to commence a securities fraud class action against DHB Industries, Inc. ("DHB") (AMEX:DHB) and certain of its officers in the U.S. District Court for the Eastern District of New York on behalf of investors who purchased the publicly traded securities of DHB during the period from April 21, 2004 through and including August 29, 2005 (the "Class Period"). As described below, if you purchased DHB publicly traded securities during the Class Period, you have until November 8, 2005 to move to be appointed as a Lead Plaintiff. DHB is a manufacturer and provider of bullet and projectile-resistant garments, including fragmentation protective vests, and related accessories. Its products are used domestically and internationally by military, law enforcement, security and corrections personnel, as well as other governmental agencies. The claims concern materially false and misleading statements made by defendants regarding DHB's business, prospects and products. On August 30, 2005 DHB announced that it has discontinued the use of Zylon(R) in its bullet resistant products and ceased production of all Zylon(R)-containing bullet resistant products on August 24, 2005. The Company also announced that it will be implementing a replacement program to assist its customers who presently have Zylon(R) body armor. The cost of this replacement program is expected to cost "no more than" $60 million -- an amount greater than DHB's trailing annual earnings before interest, taxes, depreciation and amortizations (EBITDA). DHB took this unprecedented and costly step following a determination by the National Institute of Justice ("NIJ") that it would no longer approve the purchase of bullet resistant products with Zylon(R) by law enforcement agencies. In NIJ testing, 58% of the 103 used Zylon-containing vests tested failed to stop at least one bullet in a six-shot test, evidencing a rapid degrading of Zylon(R) fibers and a reduction in the usable life of vests containing Zylon(R) by as much as 50%. During the Class Period, the CEO and other officers sold well over $220 million worth of DHB stock at an artificially inflated average price exceeding $19 per share. Upon the Company's revelation that it was withdrawing its Zylon(R) products from the market on August 30, 2005, DHB's shares fell $1.56 per share, or 23.42 percent, to close at $5.10 per share on unusually heavy trading volume. This action will seek to recover damages due to the artificial inflation of DHB's stock price caused by defendants' violations of the federal securities laws on behalf of all purchasers of DHB publicly traded securities during the Class Period. If you purchased DHB publicly traded securities during the Class Period (April 21, 2004 - August 29, 2005), you may, no later than November 8, 2005, move to be appointed as a Lead Plaintiff. A Lead Plaintiff is a representative party that acts on behalf of other class members in directing the litigation. If you have sustained losses on your purchases of DHB publicly traded securities during the Class Period, please contact Klafter & Olsen LLP at http://www.klafterolsen.com/ or call us at 202/261-3553 for a more thorough explanation of the Lead Plaintiff selection process and the claims that can be asserted against DHB. Klafter & Olsen LLP has extensive expertise in prosecuting investor class actions involving financial fraud and has offices in Washington D.C. and New York. Please visit our website for more information about the Firm. Contact: Kurt B. Olsen KLAFTER & OLSEN LLP 2121 K St., N.W., Suite 800 Washington, DC 20037 202/261-3553 DATASOURCE: Klafter & Olsen LLP CONTACT: Kurt B. Olsen of Klafter & Olsen LLP, +1-202-261-3553 Web site: http://www.klafterolsen.com/

Copyright